Drug Farm Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$55M
- Investors
-
13
Drug Farm General Information
Description
Developer of a drug discovery platform designed for the development of immune-modulating therapies. The company's technology utilizes genetic screening in living animals and artificial intelligence to identify novel drug targets, enabling the healthcare industry to access first-in-class treatments for chronic hepatitis B, rare genetic disorders, and cardio-renal diseases.
Contact Information
Website
www.drug-farm.comCorporate Office
- 69 Yuanfeng Road
- Baoshan District
- Shanghai, 200444
- China
Corporate Office
- 69 Yuanfeng Road
- Baoshan District
- Shanghai, 200444
- China
Drug Farm Timeline
Drug Farm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series D) | 13-Jul-2026 | $55M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series C) | 16-May-2023 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 02-Jun-2021 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 09-Feb-2021 | $56M | $56M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 16-Oct-2017 | Completed | Generating Revenue |
Drug Farm Comparisons
Industry
Financing
Details
Drug Farm Competitors (1)
One of Drug Farm’s competitors is Westlake Therapeutics, a Venture Capital-Backed company based in Hangzhou, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Westlake Therapeutics | Venture Capital-Backed | Hangzhou, China |
Drug Farm Patents
Drug Farm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025214420-A1 | Use of heterocyclic compound | Pending | 09-Apr-2024 | ||
| WO-2025082485-A1 | Composition and methods for the treatment of pulmonary arterial hypertension | Inactive | 19-Oct-2023 | ||
| EP-4543443-A1 | Alpha protein kinase 1 inhibitors for use in treating kidney diseases and kidney-related diseases | Pending | 29-Jun-2022 | ||
| EP-4543443-A4 | Alpha protein kinase 1 inhibitors for use in treating kidney diseases and kidney-related diseases | Pending | 29-Jun-2022 | ||
| US-20250381196-A1 | Alpha protein kinase 1 inhibitors for use in treating kidney diseases and kidney-related diseases | Pending | 29-Jun-2022 | A61K31/551 |
Drug Farm Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioMeta (Shanghai) | VC-Backed Company | Minority | ||
| HaoYue Capital | Investment Bank | Minority | ||
| Keyuan Pharma | Corporation | Minority | ||
| Shanghai Tukar Capital Management | Growth/Expansion | Minority | ||
| Betta Pharmaceutical Biotechnology Fund | Corporate Venture Capital | Minority |
Drug Farm FAQs
-
When was Drug Farm founded?
Drug Farm was founded in 2015.
-
Where is Drug Farm headquartered?
Drug Farm is headquartered in Shanghai, China.
-
What industry is Drug Farm in?
Drug Farm’s primary industry is Drug Discovery.
-
Is Drug Farm a private or public company?
Drug Farm is a Private company.
-
What is Drug Farm’s current revenue?
The current revenue for Drug Farm is .
-
How much funding has Drug Farm raised over time?
Drug Farm has raised $138M.
-
Who are Drug Farm’s investors?
BioMeta (Shanghai), HaoYue Capital, Keyuan Pharma, Shanghai Tukar Capital Management, and Betta Pharmaceutical Biotechnology Fund are 5 of 13 investors who have invested in Drug Farm.
-
Who are Drug Farm’s competitors?
Westlake Therapeutics is a competitor of Drug Farm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process